Literature DB >> 31774679

The Druggability of Solute Carriers.

Wesley Wei Wang1, Leandro Gallo1, Appaso Jadhav1, Richard Hawkins1, Christopher G Parker1,2.   

Abstract

The transport of materials across membranes is a vital process for all aspects of cellular function, including growth, metabolism, and communication. Protein transporters are the molecular gates that control this movement and serve as key points of regulation for these processes, thus representing an attractive class of therapeutic targets. With more than 400 members, the solute carrier (SLC) membrane transport proteins are the largest family of transporters, yet, they are pharmacologically underexploited relative to other protein families and many of the available chemical tools possess suboptimal selectivity and efficacy. Fortuitously, there is increased interest in elucidating the physiological roles of SLCs as well as growing recognition of their therapeutic potential. This Perspective provides an overview of the SLC superfamily, including their biochemical and functional features, as well as their roles in various human diseases. In particular, we explore efforts and associated challenges toward drugging SLCs, as well as highlight opportunities for future drug discovery.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31774679     DOI: 10.1021/acs.jmedchem.9b01237

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  20 in total

Review 1.  The PROTACtable genome.

Authors:  Melanie Schneider; Chris J Radoux; Andrew Hercules; David Ochoa; Ian Dunham; Lykourgos-Panagiotis Zalmas; Gerhard Hessler; Sven Ruf; Veerabahu Shanmugasundaram; Michael M Hann; Pam J Thomas; Markus A Queisser; Andrew B Benowitz; Kris Brown; Andrew R Leach
Journal:  Nat Rev Drug Discov       Date:  2021-07-20       Impact factor: 84.694

Review 2.  Genetics of common cerebral small vessel disease.

Authors:  Constance Bordes; Muralidharan Sargurupremraj; Aniket Mishra; Stéphanie Debette
Journal:  Nat Rev Neurol       Date:  2022-01-05       Impact factor: 42.937

3.  Integrative multi-omics landscape of fluoxetine action across 27 brain regions reveals global increase in energy metabolism and region-specific chromatin remodelling.

Authors:  Vibhor Kumar; Jonathan Aow; Naghmeh Rastegar; Michelle Gek Liang Lim; Nicholas O'Toole; Nirmala Arul Rayan; Edita Aliwarga; Danusa Mar Arcego; Hui Ting Grace Yeo; Jen Yi Wong; May Yin Lee; Florian Schmidt; Hajira Shreen Haja; Wai Leong Tam; Tie-Yuan Zhang; Josie Diorio; Christoph Anacker; Rene Hen; Carine Parent; Michael J Meaney; Shyam Prabhakar
Journal:  Mol Psychiatry       Date:  2022-09-02       Impact factor: 13.437

Review 4.  A guide to plasma membrane solute carrier proteins.

Authors:  Mattia D Pizzagalli; Ariel Bensimon; Giulio Superti-Furga
Journal:  FEBS J       Date:  2020-09-18       Impact factor: 5.542

Review 5.  Shortcut Approaches to Substance Delivery into the Brain Based on Intranasal Administration Using Nanodelivery Strategies for Insulin.

Authors:  Toshihiko Tashima
Journal:  Molecules       Date:  2020-11-07       Impact factor: 4.411

6.  A study of the dopamine transporter using the TRACT assay, a novel in vitro tool for solute carrier drug discovery.

Authors:  Hubert J Sijben; Julie J E van den Berg; Jeremy D Broekhuis; Adriaan P IJzerman; Laura H Heitman
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

Review 7.  Membrane Transport Proteins in Osteoclasts: The Ins and Outs.

Authors:  Amy B P Ribet; Pei Ying Ng; Nathan J Pavlos
Journal:  Front Cell Dev Biol       Date:  2021-02-26

8.  Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors.

Authors:  Hubert J Sijben; Wieke M van Oostveen; Peter B R Hartog; Laura Stucchi; Andrea Rossignoli; Giovanna Maresca; Lia Scarabottolo; Adriaan P IJzerman; Laura H Heitman
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

9.  Cannabinoid Receptors Overexpression in a Rat Model of Irritable Bowel Syndrome (IBS) after Treatment with a Ketogenic Diet.

Authors:  Isabella Gigante; Valeria Tutino; Francesco Russo; Valentina De Nunzio; Sergio Coletta; Raffaele Armentano; Alberto Crovace; Maria Gabriella Caruso; Antonella Orlando; Maria Notarnicola
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

10.  Solute carrier transporter superfamily member SLC16A1 is a potential prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma.

Authors:  Jiaheng Xie; Zhechen Zhu; Yuan Cao; Shujie Ruan; Ming Wang; Jingping Shi
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.